NDC product
Benzonatate 100 mg
NDC 25000-002 · MARKSANS PHARMA LIMITED
Key facts
| Product NDC | 25000-002 |
|---|---|
| Proprietary name | Benzonatate 100 mg |
| Nonproprietary name | Benzonatate 100 mg |
| Substances | BENZONATATE |
| Dosage form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Labeler | MARKSANS PHARMA LIMITED |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA220298 |
| Pharmacologic classes | Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC] |
| Marketing start | Apr 10, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: